NRG Therapeutics Ltd. (“NRG”), a clinical stage neuroscience company targeting a novel mechanism to rectify mitochondrial ...
QRL-101, an oral small molecule being developed by QurAlis, was safe and reduced nerve-cell overactivity in ALS patients in ...
Clinical Trials Arena on MSN
NRG doses first participants in Phase I trial for ALS and Parkinson’s
NRG Therapeutics has dosed the first participants in its Phase I clinical trial of NRG5051, being developed as a ...
Stevenage, United Kingdom Saturday, January 10, 2026, 14:00 Hrs [IST] ...
Motor neuron diseases, such as amyotrophic lateral sclerosis (ALS) and hereditary spastic paraplegia (HSP), share physical similarities but have been largely viewed as genetically distinct. However, ...
A small molecule known as 10H-phenothiazine reduced the loss of motor neurons, the nerve cells that are lost in SMA, in ...
DelveInsight’s, “Motor Neuron Disease- Pipeline Insight, 2025” report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in Motor Neuron Disease pipeline landscape. It covers ...
Motor neurons are specialised nerve cells that carry signals from the brain to the muscles, allowing the body to perform voluntary movements. These neurons are divided into two key types:- Upper motor ...
Changes in motor units closely reflect disease severity in people with spinal muscular atrophy (SMA), suggesting potential ...
Leeds Rhinos confirmed Burrow's passing in a heartfelt statement: \"It is with deep sadness that the club can confirm that former player Rob Burrow CBE has passed away, aged 41. Rob inspired the ...
Using machine learning models, researchers at Michigan Medicine have identified a potential way to diagnose amyotrophic lateral sclerosis, or ALS, earlier from a blood sample, a study suggests. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback